Is GLP-1 Medication Worth It If You're 80-90 kg? A Realistic Guide for Indians

By GLP1Score Team | Published 2026-04-03 | 12 min read

You weigh 80-90 kg. You don't look like the "before" photos in weight loss ads. Your friends say you're "not that heavy." Your family says "just eat less roti." But your clothes don't fit right, your knees hurt, your blood sugar is creeping up, and you've been trying to lose weight for years.

Should you consider GLP-1 medication like semaglutide or tirzepatide? Or is it "too extreme" for someone at your weight?

The short answer: for many Indians at 80-90 kg, GLP-1 medication isn't extreme at all. It might be exactly what you need. But it depends on your height, your health conditions, your history, and whether you've genuinely exhausted other options first.

Let's break this down honestly.

Why 80-90 kg Matters More in India Than You Think

Western BMI cutoffs don't work well for South Asians. The standard WHO threshold for obesity is BMI 30. But the WHO Asia-Pacific guidelines and India's own medical bodies use lower cutoffs because South Asians develop metabolic complications at lower BMI levels:

Normal weight: BMI 18.5–22.9 (vs 18.5–24.9 Western)
Overweight: BMI 23–24.9 (vs 25–29.9 Western)
Obese: BMI ≥25 (vs ≥30 Western)

Here's what 80-90 kg actually means at common Indian heights:

Height	Weight	BMI	Category (Asian cutoffs)
5'0" (152 cm)	80 kg	34.6	Obese Class II
5'2" (157 cm)	80 kg	32.4	Obese Class I
5'4" (163 cm)	80 kg	30.1	Obese Class I
5'4" (163 cm)	90 kg	33.9	Obese Class II
5'6" (168 cm)	80 kg	28.3	Overweight
5'6" (168 cm)	90 kg	31.9	Obese Class I
5'8" (173 cm)	85 kg	28.4	Overweight
5'8" (173 cm)	90 kg	30.1	Obese Class I
5'10" (178 cm)	90 kg	28.4	Overweight

Look at that table carefully. A woman who is 5'4" and 80 kg has a BMI of 30.1. By Asian cutoffs, she's well into the obese range. By Western standards, she would barely qualify. This discrepancy is why many Indian patients are told they're "not heavy enough" for treatment when they absolutely are.

The reason for lower cutoffs is biological. South Asians carry more visceral fat (fat around organs) at the same BMI compared to Europeans. This visceral fat is far more metabolically dangerous than subcutaneous fat (fat under the skin). An Indian man at BMI 27 may have the same metabolic risk as a European man at BMI 32.

Find out if your weight and health profile qualify you for GLP-1 medication. Takes just 2 minutes.

Check My Eligibility Now

The Metabolic Risk at 80-90 kg for Indians

At 80-90 kg, many Indians already have one or more of the following — even if they feel "fine":

Insulin resistance. Your cells don't respond well to insulin, so your body produces more. Your fasting insulin may be high (above 12 µU/mL) even though your fasting glucose looks normal. This is the precursor to diabetes. A simple HbA1c test can reveal whether you're already prediabetic.
Prediabetes. HbA1c between 5.7-6.4%. An estimated 136 million Indians are prediabetic as of 2025. Many don't know it. At 80-90 kg with a sedentary lifestyle, the probability is high.
Non-alcoholic fatty liver disease (NAFLD). Fat deposits in the liver. Affects an estimated 30-40% of urban Indians. Often has no symptoms until it's advanced. An ultrasound can detect it. Weight loss of just 7-10% can reverse early-stage NAFLD.
Dyslipidemia. High triglycerides, low HDL. The classic "Indian lipid profile." Driven by visceral fat, carb-heavy diets, and genetics.
Elevated blood pressure. Even mildly elevated BP (130-139/80-89) qualifies as Stage 1 hypertension. Common at this weight range, especially with high sodium intake.
Sleep apnea. If you snore heavily, wake up tired, or your partner says you stop breathing at night — you may have obstructive sleep apnea. It's underdiagnosed in India. Weight loss significantly improves it.

The important thing to understand: you don't need to have diabetes to benefit from GLP-1 medication. You need to have metabolic risk. And at 80-90 kg, most Indians do.

PCOS and GLP-1 — A Strong Combination

If you're a woman with PCOS (Polycystic Ovary Syndrome), GLP-1 medication might be one of the most effective tools available to you right now. Here's why.

PCOS is fundamentally driven by insulin resistance. Your body overproduces insulin, which stimulates the ovaries to produce excess androgens (male hormones). This causes irregular periods, acne, hirsutism (excess hair growth), difficulty losing weight, and infertility.

GLP-1 medications like semaglutide directly address insulin resistance. In studies on women with PCOS:

Semaglutide reduced body weight by 10-15% over 6-12 months
Fasting insulin levels dropped significantly
Menstrual cycles became more regular in 60-70% of women
Testosterone levels decreased, improving acne and hirsutism
Some women who were previously anovulatory started ovulating again

Currently, semaglutide is not officially approved for PCOS in India. It's used off-label — meaning doctors prescribe it for PCOS based on clinical evidence and guidelines, even though the official indication is diabetes or obesity. This is common medical practice and completely legal.

The typical candidate for GLP-1 + PCOS treatment: a woman with PCOS, BMI 27 or above (by Asian cutoffs), who has already tried metformin and lifestyle changes without adequate results. If this describes you, bring it up with your endocrinologist or gynaecologist.

Metformin is usually tried first for PCOS because it's cheaper (₹5-15/month) and well-established. But if metformin alone hasn't been enough — which is common — adding or switching to semaglutide is a reasonable next step. Some doctors use both together.

Psychiatric Medications and Weight

This section is here because it's an extremely common and rarely discussed issue. Many Indians at 80-90 kg are on psychiatric medications that contribute significantly to their weight — and they don't realise how much.

Medications that commonly cause weight gain:

SSRIs: Paroxetine (Paxidep) and sertraline (Daxid) are the worst offenders. Average weight gain: 2-5 kg over 6-12 months. Escitalopram (Nexito) is more weight-neutral.
Atypical antipsychotics: Olanzapine (Oleanz) is notorious — patients can gain 5-15 kg in the first year. Quetiapine (Quel) and risperidone (Risperdal) also cause weight gain but less severely.
Mood stabilizers: Lithium and valproate (Encorate) both cause weight gain. Lamotrigine is weight-neutral.
Pregabalin (Lyrica/Pregabid): Used for anxiety and nerve pain. Causes weight gain in about 10-15% of users.

GLP-1 medication can counteract medication-induced weight gain. Emerging research shows semaglutide is effective even when weight gain is driven by psychiatric drugs. But — and this is crucial — both your psychiatrist and your endocrinologist need to be on the same page.

Never stop psychiatric medication to lose weight. The risks of untreated depression, anxiety, bipolar disorder, or psychosis far outweigh the risks of being overweight. The right approach is to add GLP-1 medication while continuing your psychiatric treatment, with both doctors coordinating.

If you're on olanzapine specifically, ask your psychiatrist if switching to aripiprazole (Abilify) is an option — it's the most weight-neutral atypical antipsychotic. But this is a decision for your psychiatrist, not something to do on your own.

The Real Question: Have You Already Tried Everything?

GLP-1 medication is not a first-line treatment for someone who has never tried diet and exercise. It's meant for people who have genuinely tried and struggled. Most prescribing guidelines and responsible doctors require evidence of prior effort.

Before considering GLP-1 medication, you should have:

Attempted structured diet and exercise for at least 6 months. Not "I tried eating less for 2 weeks." A genuine, sustained effort — calorie tracking, regular exercise, professional guidance if possible.
Tried metformin (if you have insulin resistance, prediabetes, or PCOS). At adequate doses (1,500-2,000 mg/day) for at least 3-6 months.
Documented comorbidities — blood tests showing prediabetes, elevated insulin, fatty liver on ultrasound, high triglycerides, high blood pressure, or PCOS diagnosis.
A realistic understanding of what GLP-1 does. It's not magic. Average weight loss is 15-17% of body weight. For someone at 85 kg, that's about 13-14 kg over 12-16 months. You'll still need to eat well and exercise for best results.

If you've done all of the above and you're still at 80-90 kg with metabolic issues, you are a legitimate candidate. You deserve treatment. Don't let anyone tell you you're "not heavy enough."

Semaglutide vs Mounjaro for This Weight Range

At 80-90 kg, you may not need the maximum dose of either drug. This is important because it affects cost significantly.

Generic semaglutide is the most cost-effective option. Many patients in this weight range see good results at 1.0-1.7 mg/week, without needing to escalate to 2.4 mg. Monthly cost with generics: ₹1,290-4,200 depending on brand and dose. Read our complete generic semaglutide price guide for brand-by-brand comparisons.

Tirzepatide (Mounjaro) is a dual GIP/GLP-1 agonist that shows slightly higher average weight loss in clinical trials (20-22% vs 15-17%). But it costs ₹9,200/month in India and has no generic versions yet. For most patients at 80-90 kg, the additional 3-5% weight loss doesn't justify tripling the cost.

The practical recommendation: start with generic semaglutide. It's affordable, effective, and widely available. If after 6-12 months at maximum dose you haven't reached your goals, discuss switching to Mounjaro with your doctor. Going from semaglutide to tirzepatide is a recognized clinical pathway.

Want a personalised assessment of whether GLP-1 medication makes sense for your weight and health conditions? Take our free quiz.

Take the Eligibility Quiz

The Cost-Benefit Math

Let's do the actual maths. Is GLP-1 medication worth the money at 80-90 kg?

Cost of 12 months of generic semaglutide:

Budget option (Natco Semanat vial): ₹1,290/month × 12 = ₹15,480/year
Mid-range (Alkem/Zydus pen): ₹2,200/month × 12 = ₹26,400/year
Premium generic (Dr. Reddy's Obeda): ₹4,200/month × 12 = ₹50,400/year

Now compare that to things Indians routinely spend money on:

Gym membership (largely unused): ₹25,000-40,000/year. Studies show 80% of gym members stop going within 3 months but keep paying.
Diet programs and weight loss supplements: ₹10,000-50,000/year on things like Herbalife, keto diet plans, detox teas, and "fat burner" supplements — most of which have zero clinical evidence.
Eating out frequently: ₹2,000-5,000/month on restaurants and Zomato/Swiggy. That's ₹24,000-60,000/year — often on the high-calorie food that contributed to the weight gain.

And compare to the cost of NOT treating obesity:

Type 2 diabetes management: ₹2,00,000-5,00,000+ per year when you include medication, doctor visits, blood tests, and complications management. Diabetes is a lifelong condition once it develops.
Knee replacement surgery: ₹3,00,000-5,00,000 per knee. Obesity is the number one modifiable risk factor for knee osteoarthritis. Losing 10-15 kg at age 35-45 can prevent the need for knee replacement at age 55-65.
Heart disease treatment: A single angioplasty costs ₹2,00,000-4,00,000. Bypass surgery: ₹3,00,000-6,00,000.
PCOS fertility treatment: IVF cycles cost ₹1,50,000-3,00,000 each. Many women with PCOS need multiple cycles. Weight loss of 10% can restore natural ovulation in many cases.

When you frame it this way: spending ₹15,000-50,000 per year on a clinically proven medication that reduces your risk of diabetes, heart disease, and joint problems — while also improving your quality of life, energy, and self-confidence — is one of the better health investments you can make.

You're not just paying for weight loss. You're paying for metabolic health, reduced disease risk, and years of better living.

How to Have the Conversation with Your Doctor

Many Indian patients feel awkward asking their doctor about weight loss medication. Some doctors are also not proactive about suggesting it. Here's how to approach the conversation effectively.

Come prepared with:

Recent blood work: HbA1c, fasting glucose, fasting insulin, lipid profile (total cholesterol, LDL, HDL, triglycerides), thyroid panel (TSH, T3, T4), liver function test, and kidney function test. Get these done at a diagnostic lab (SRL, Thyrocare, Dr Lal PathLabs) for ₹1,500-3,000 total.
Your weight loss history: What you've tried, for how long, and what the results were. "I did calorie restriction at 1,400 cal/day for 4 months and lost 3 kg, which I regained within 2 months" is much more compelling than "I've tried everything."
A list of all your medications. Include psychiatric medications, supplements, and anything prescribed by other doctors.
An ultrasound report — if you've had one. Fatty liver findings strengthen the case for treatment.
Your specific concern. "I'm worried about progressing to diabetes" or "I have PCOS and metformin alone isn't enough" or "I need to lose weight before my knee replacement can be scheduled."

Which doctor to see:

Endocrinologist — best choice for most patients. They specialise in metabolic disorders and are most experienced with GLP-1 prescribing.
Diabetologist — if your primary issue is blood sugar or prediabetes.
Gynaecologist/reproductive endocrinologist — if PCOS is your primary concern.
Obesity medicine specialist — available at larger hospitals like Apollo, Fortis, Max.

What to say: "I've been struggling with weight for [X years]. I've tried [specific methods] with limited success. My blood work shows [specific findings]. I've been reading about GLP-1 medication and I'd like to discuss whether it's appropriate for me."

A good doctor will evaluate your case and give you an honest answer. If they dismiss you without looking at your bloodwork or history, consider getting a second opinion. You have the right to explore evidence-based treatment options.

If you want a quick preliminary check before booking a doctor's appointment, our eligibility quiz can help you understand whether your profile matches the typical GLP-1 candidate. It takes 2 minutes and it's free.

Back to Blog | Compare Brands | Check Your Eligibility — Free